LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Operating Expenses Summary of LegoChem Biosciences, Inc.

  • LegoChem Biosciences, Inc.'s latest annual operating expenses in 2023 was 98.61 Billion KRW , up 37.15% from previous year.
  • LegoChem Biosciences, Inc.'s latest quarterly operating expenses in 2024 Q2 was 36.48 Billion KRW , up 55.84% from previous quarter.
  • LegoChem Biosciences, Inc. reported a annual operating expenses of 70.87 Billion KRW in annual operating expenses 2022, up 35.41% from previous year.
  • LegoChem Biosciences, Inc. reported a annual operating expenses of 52.33 Billion KRW in annual operating expenses 2021, down -19.72% from previous year.
  • LegoChem Biosciences, Inc. reported a quarterly operating expenses of 23.83 Billion KRW for 2024 Q1, down -21.41% from previous quarter.
  • LegoChem Biosciences, Inc. reported a quarterly operating expenses of 21.06 Billion KRW for 2023 Q1, down -31.9% from previous quarter.

Annual Operating Expenses Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Operating Expenses of LegoChem Biosciences, Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 98.61 Billion KRW 37.15%
2022 70.87 Billion KRW 35.41%
2021 52.33 Billion KRW -19.72%
2020 65.19 Billion KRW 148.3%
2019 26.25 Billion KRW 13.71%
2018 23.09 Billion KRW 53.14%
2017 15.07 Billion KRW 17.3%
2016 12.85 Billion KRW 0.0%

Peer Operating Expenses Comparison of LegoChem Biosciences, Inc.

Name Operating Expenses Operating Expenses Difference
HLB Co., Ltd. 109.98 Billion KRW 10.335%
iNtRON Biotechnology, Inc. 7.84 Billion KRW -1156.968%
BINEX Co., Ltd. 55.67 Billion KRW -77.132%
Bioneer Corporation 204.55 Billion KRW 51.789%
Anterogen.Co.,Ltd. 7.74 Billion KRW -1174.123%
MEDIPOST Co., Ltd. 65.31 Billion KRW -50.991%
CrystalGenomics, Inc. 32.36 Billion KRW -204.664%
Helixmith Co., Ltd 37.36 Billion KRW -163.92%
Chabiotech Co.,Ltd. 285.93 Billion KRW 65.51%
Medy-Tox Inc. 110.88 Billion KRW 11.062%
Peptron, Inc. 16.65 Billion KRW -492.076%
Amicogen, Inc. 52.82 Billion KRW -86.697%
Genexine, Inc. 41.62 Billion KRW -136.905%
HLB Therapeutics Co.,Ltd. 16.16 Billion KRW -510.025%
ALTEOGEN Inc. 40.93 Billion KRW -140.915%
PharmaResearch Co., Ltd. 89.44 Billion KRW -10.262%
SillaJen, Inc. 5.11 Billion KRW -1829.085%
JETEMA, Co., Ltd. 25.66 Billion KRW -284.267%
OliX Pharmaceuticals,Inc 35.24 Billion KRW -179.775%
Genomictree Inc. 16.26 Billion KRW -506.334%
MedPacto, Inc. 26.91 Billion KRW -266.351%
D&D Pharmatech 32.16 Billion KRW -206.622%
EASY BIO,Inc. 29.67 Billion KRW -232.366%
GI Innovation, Inc. 57.59 Billion KRW -71.235%